https://seekingalpha.com/news/4453950-carlyle-sk-capital-partners-disclose-expected-closing-date-of-bluebird-bio-deal?source=feed_sector_healthcare
May 30, 2025 -
0
sa:3075256883991290596
0
https://seekingalpha.com/news/4451642-instil-bio-shares-rise-on-immunotherapy-trial-updates?source=feed_sector_healthcare
May 22, 2025 -
0
sa:907925579062549175
0
https://seekingalpha.com/article/4787752-bio-key-international-inc-bkyi-q1-2025-earnings-call-transcript?source=feed_sector_transcripts
May 16, 2025 -
0
sa:1952574548944778402
0
https://www.rttnews.com/story.aspx?Id=3539124
May 14, 2025 - bluebird bio, Inc. (BLUE), a biotechnology company, Carlyle (CG) and SK Capital Partners, LP Wednesday said they have amended their agreement pursuant to which Carlyle and SK Capital will purchase all outstanding shares of bluebird. bluebird bio shares were more than 50% up in pre-market.
0
rttnews:-2096991245757784421
0
https://seekingalpha.com/article/4785431-nuvation-bio-inc-nuvb-q1-2025-earnings-call-transcript?source=feed_sector_transcripts
May 11, 2025 -
0
sa:-1548799086417534489
0
https://seekingalpha.com/news/4446072-entera-bio-gaap-eps-of-0_06-beats-by-0_01?source=feed_tag_israel
May 09, 2025 -
0
sa:-5660174421956266312
0
https://seekingalpha.com/news/4441277-carlyle-group-sk-capital-secure-all-regulatory-approvals-to-acquire-bluebird-bio?source=feed_sector_healthcare
May 05, 2025 -
0
sa:5622930163353091017
0
https://seekingalpha.com/article/4780940-bio-rad-laboratories-inc-bio-q1-2025-earnings-call-transcript?source=feed_sector_transcripts
May 01, 2025 -
0
sa:-2650018342765485860
0
https://seekingalpha.com/news/4430929-inmune-bio-partners-with-cell-and-gene-therapy-catapult?source=feed_sector_healthcare
Apr 14, 2025 -
0
sa:4090103081081243406
0
https://seekingalpha.com/news/4430863-third-harmonic-bio-plans-to-liquidate-the-company-sell-urticaria-treatment?source=feed_sector_healthcare
Apr 14, 2025 -
0
sa:-6605382308906121405
0